Zekun Li

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 10

Top Topics

Magnetic Resonance

Top Venues

Research and practice in thrombosis and haemostasis

Haemophilia : the official journal of the World Federation of Hemophilia

International journal of immunopathology and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Sun, Zekun Li, Huang Kun, Di Ai, Gang Li, Xingjuan Xie, Hao Gu, Guoqing Liu, Yingzi Zhen, Zhenping Chen, Runhui Wu
F8 gene mutation spectrum in severe hemophilia A with inhibitors: A large cohort data analysis from a single center in China. Research and practice in thrombosis and haemostasis 6 (4) (2022)
Jie Sun, Zekun Li, Gang Li, Huang Kun, Di Ai, Guoqing Liu, Wanru Yao, Xingjuan Xie, Hao Gu, Yingzi Zhen, Zhenping Chen, Runhui Wu
Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: Type of factor 8 mutation and outcomes. Research and practice in thrombosis and haemostasis 6 (7) (2022)
Zekun Li, Guoqing Liu, Wanru Yao, Zhenping Chen, Gang Li, Xiaoling Cheng, Yingzi Zhen, Di Ai, Huang Kun, Jie Sun, Man-Chiu Poon, Runhui Wu
Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in China. Haemophilia : the official journal of the World Federation of Hemophilia 28 (4) (2022)
Di Hu, Jingran Liu, Guoqing Liu, Shasha Hu, Zekun Li, Yunyun Wei, Ningning Zhang, Runhui Wu, Yun Peng
Altered brain activity and functional networks in school-age boys with severe haemophilia A: A resting-state functional magnetic resonance imaging study. Haemophilia : the official journal of the World Federation of Hemophilia 28 (4) (2022)
Guoqing Liu, Jie Sun, Zekun Li, Zhenping Chen, Wenman Wu, Runhui Wu
F9 mutations causing deletion beyond serine protease domain confer higher risk for inhibitor development in hemophilia B. Blood (2022)
Zekun Li, Zhenping Chen, Guoqing Liu, Xiaoling Cheng, Wanru Yao, Huang Kun, Gang Li, Yingzi Zhen, Xinyi Wu, Siyu Cai, Man-Chiu Poon, Runhui Wu
Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors. Research and practice in thrombosis and haemostasis 5 (5) (2021)
Zekun Li, Zhenping Chen, Xiaoling Cheng, Xinyi Wu, Gang Li, Yingzi Zhen, Man-Chiu Poon, Runhui Wu
A previously treated severe haemophilia A patient developed high-titre inhibitor after vaccinations. International journal of immunopathology and pharmacology 34 (2021)
Zekun Li, Guoqing Liu, Wanru Yao, Zhenping Chen, Gang Li, Xiaoling Cheng, Yingzi Zhen, Di Ai, Huang Kun, Man-Chiu Poon, Runhui Wu
Nephrotic syndrome in two haemophilia B children with inhibitor under low-dose immune tolerance induction combined with rituximab-based immunosuppressant protocol. Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2021)
Zekun Li, Zhenping Chen, Xiaoling Cheng, Guoqing Liu, Xinyi Wu, Gang Li, Zhenping Chen, Siyu Cai, Man-Chiu Poon, Runhui Wu
A low-dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high-titre factor VIII inhibitor and poor-ITI prognostic risk. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2020)
Zekun Li, Zhenping Chen, Xiaoling Cheng, Xinyi Wu, Gang Li, Yingzi Zhen, Siyu Cai, Man-Chiu Poon, Runhui Wu
Low-dose immune tolerance induction for children with hemophilia A with poor-risk high-titer inhibitors: A pilot study in China. Research and practice in thrombosis and haemostasis 3 (4) (2019)